CytomX Therapeutics (CTMX) Has Jumped To A 10-Month High On Bristol-Myers Deal

Shutterstock photo

( - Bristol-Myers Squibb ( BMY ) announced an expansion of its 2014 strategic collaboration with CytomX Therapeutics Inc. ( CTMX ) Monday morning. CytomX will receive $200 million upfront payment.

CytomX Therapeutics has gapped open sharply higher Monday morning and is now up 3.64 at $18.82 on strong volume. The stock has jumped to over a 10-month high.

For comments and feedback: contact

This article appears in: Stocks , Stocks
Referenced Symbols: BMY , CTMX

More from RTT News


See headlines for BMY

Follow on: